Recent Finacing
Recent Raise
Collegium Pharmaceutical develops abuse‑deterrent extended‑release medications using its patent‑protected DETERx multi‑particulate matrix platform, producing tamper‑resistant oxycodone capsules (Xtampza ER/COL‑003) with flexible administration.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors